MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

510887

Report Date :

25.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

WINDLAS BIOTECH PRIVATE LIMITED (w.e.f 22.07.2016)

 

 

Formerly Known As :

WINDLAS BIOTECH LIMITED

 

 

Registered Office :

40/1, Mohabewala Industrial Area, Dehradun – 248110, Uttarakhand

Tel. No.:

91-135-6608000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

19.02.2001

 

 

Com. Reg. No.:

20-033407

 

 

Capital Investment / Paid-up Capital :

INR 85.294 Million

 

 

CIN No.:

[Company Identification No.]

U74899UR2001PTC033407

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACW3417C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in business of manufacture of allopathic pharmaceuticals preparations. [Registered Activity]

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 4300000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2001 having satisfactory track record. It is a manufacturer and exporter of pharmaceutical products.

 

For the financial year 2017, the company has achieved decent growth in its revenue as compared to its previous year along with average profitability margin during the year.

 

Rating takes into consideration the satisfactory financial profile marked by strong net worth base along with and moderate debt coverage indicators due to low debt balance sheet profile and favourable liquidity position.

 

Rating continue to derive strength from its established track record of its business operation backed by its well experienced management team.

 

However, these rating strengths gets partially offset by exposure  to  regulatory  changes,  especially  related  to  pricing  of  pharmaceutical  product.

 

Payments seems to be regular.

 

In view aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating= A-

Rating Explanation

Adequate degree of safety and low credit risk.

Date

28.03.2017

 

Rating Agency Name

CRISIL

Rating

Short Term Rating= A2+

Rating Explanation

Strong degree of safety and low credit risk.

Date

28.03.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 25.05.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED BY

 

Name :

Not Divulged

Designation :

Accountant

Contact No.:

91-135-6608000

Date :

24.05.2018

 

Management Non-Cooperative (91-124-2821030)

 

LOCATIONS

 

Registered Office / Factory 1:

40/1, Mohabewala, Industrial Rea, Dehradun – 248110, Uttarakhand, India

Tel. No.:

91-135-6608000-30

Fax No.:

91-135-6608199

E-Mail :

cs@windlasbiotech.com

info@windlasbiotech.com

Website :

http://www.windlasbiotech.com

 

 

Corporate Office :

705-706, Vatika Professional Point, Sector-66, Golf Course Road, Gurugram – 122001, Haryana, India

Tel. No.:

91-124-2821030

Fax No.:

91-124-2821060

 

 

Factory 2:

Khasra No.141 to 143 and 145, Mahabewala Industrial Area, Dehradun – 248110, Uttarakhand, India

 

 

Factory 3:

Plot No.39, Pharma city, Industrial Area, Selaqui, Dehradun – 248197, Uttarakhand, India

 

 

DIRECTORS

 

AS ON 31.03.2018

 

Name :

Mr. Ashok Kumar Windlass

Designation :

Managing Director

Address :

53 R, Rajpur Road, Dehradun – 248110, Uttarakhand, India

Date of Birth/Age :

23.10.1950

Date of Appointment :

19.02.2001

PAN No.:

AABPW4101H

DIN No :

00011451

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U74899DL1989PTC037847

G.J.W. MARKETING AND SERVICES PRIVATE LIMITED

25/11/1999

-

U85100UR2010PTC033065

WINDLAS HEALTHCARE PRIVATE LIMITED

17/09/2015

-

U74120UR2011PTC033397

WINDLAS EXPORTS PRIVATE LIMITED

01/02/2011

-

 

 

Name :

Mr. Manoj Kumar Windlass

Designation :

Director

Address :

53 R, Rajpur Road, Dehradun – 248110, Uttarakhand, India

Date of Birth/Age :

24.09.1978

Date of Appointment :

15.09.2010

PAN No.:

AAUPW7335G

DIN No :

00221671

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U85100UR2010PTC033065

WINDLAS HEALTHCARE PRIVATE LIMITED

28/09/2010

-

U74120UR2011PTC033397

WINDLAS EXPORTS PRIVATE LIMITED

01/02/2011

-

 

 

Name :

Mr. Hitesh Windlass

Designation :

Director

Address :

53 R, Rajpur Road, Dehradun – 248110, Uttarakhand, India

Date of Birth/Age :

06.01.1977

Date of Appointment :

15.09.2010

PAN No.:

AABPW4150G

DIN No

02030941

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U85100UR2010PTC033065

WINDLAS HEALTHCARE PRIVATE LIMITED

01/10/2015

-

U51909HR2010PTC052394

MEDICINES COMPANY (INDIA) PRIVATE LIMITED

28/12/2010

-

 

 

Name :

Ms. Hetal Madhukant Gandhi

Designation :

Director

Address :

B/2,1203, Vivarea Sane Guruji Marg, Jacob Circle, Mahalaxmi, Mumbai – 400011, Maharashtra, India

Date of Birth/Age :

29.07.1965

Date of Appointment :

03.12.2015

DIN No

00106895

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U74999MH2005PTC156242

TANO INDIA ADVISORS PRIVATE LIMITED

28/08/2014

-

U60232GJ2007PLC049796

SHREE SHUBHAM LOGISTICS LIMITED

24/07/2013

-

U28939PN1987PLC043673

VIRGO ENGINEERS LTD

18/10/2006

-

U55101MH1986PTC038538

CHALET HOTELS PRIVATE LIMITED

20/03/2003

-

 

 

KEY EXECUTIVES

 

Name :

Mr. Anjan Kumar

Designation :

Company Secretary

Address :

16/12, Guru Road, Dehradun – 248001, Uttarakhand, India

Date of Appointment :

12.10.2010

PAN No.:

AWCPK4354K

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders (Equity Shares)

 

No. of Shares

Ashok Kumar Windlass

4417642

Vimla Windlass

500000

Vani Windlass

1

Manoj Kumar Windlass

1

Hitesh Windlass

1

Prachi Windlass

1

Payal Windlass

1

Tano India Private Equity Fund-II, Mauritius 

670589

 

 

Total

5588236

 

 

Names of Shareholders (Preference Shares)

 

No. of Shares

Tano India Private Equity Fund-II, Mauritius 

294117

 

 

Total

294117

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 27.09.2017

 

Category

Percentage

Promoters [Individual/Hindu Undivided Family (Indian)]

88.00

Public/Other than promoters [Body corporate]

12.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in business of manufacture of allopathic pharmaceuticals preparations. [Registered Activity]

 

 

Products / Services :

Name and Description of main products / services

ITC Code

Pharmaceutical Formulation

30049099

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Banker Name :

HDFC Bank Limited

Branch :

HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Facilities :

SECURED LOANS

31.03.2017

INR In Million

31.03.2016

INR In Million

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

141.368

154.152

Rupee term loans from others

40.511

46.173

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

332.242

0.232

Loans repayable on demand from others

0.000

239.036

 

 

 

Total

514.121

439.593

 

Auditors :

 

Name :

S.S. Kothari Mehta and Company

Chartered Accountants

Address :

146-148, Tribhuwan Complex, Ishwar Nagar Mathura Road, New Delhi – 110065, India

PAN No.:

AABFS6730L

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary company :

·         Windlas Healthcare Private Limited

 

 

Other related party :

·         Medicines Company India Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 27.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

INR 10/- each

INR 60.000 Million

300000

Preference Shares

INR 100/- each

INR 30.000 Million

 

 

 

 

 

Total

 

INR 90.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5588236

Equity Shares

INR 10/- each

INR 55.882 Million

294117

Preference Shares

INR 100/- each

INR 29.412 Million

 

 

 

 

 

Total

INR 85.294 Million

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

85.294

85.294

50.000

(b) Reserves & Surplus

1412.979

1321.313

590.251

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1498.273

1406.607

640.251

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

181.879

200.325

174.913

(b) Deferred tax liabilities (Net)

0.000

0.000

1.557

(c) Other long term liabilities

0.400

1.250

2.050

(d) Long-term provisions

13.844

4.629

3.444

Total Non-current Liabilities (3)

196.123

206.204

181.964

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

332.242

239.268

539.877

(b) Trade payables

766.724

760.053

535.827

(c) Other current liabilities

242.586

198.192

104.000

(d) Short-term provisions

1.279

0.728

0.181

Total Current Liabilities (4)

1342.831

1198.241

1179.885

 

 

 

 

TOTAL

3037.227

2811.052

2002.100

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

553.865

555.802

552.155

(ii) Intangible Assets

8.096

4.738

0.652

(iii) Capital work-in-progress

151.380

91.474

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

911.844

651.844

102.244

(c) Deferred tax assets (net)

4.654

6.948

0.000

(d) Long-term Loan and Advances

58.259

51.693

225.815

(e) Other Non-current assets

0.982

3.579

2.769

Total Non-Current Assets

1689.080

1366.078

883.635

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

300.400

300.400

0.000

(b) Inventories

399.045

270.951

322.057

(c) Trade receivables

606.903

552.171

678.630

(d) Cash and cash equivalents

22.067

289.911

78.642

(e) Short-term loans and advances

19.732

31.541

39.136

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1348.147

1444.974

1118.465

 

 

 

 

TOTAL

3037.227

2811.052

2002.100

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

3160.970

2735.320

2588.296

 

Other Income

28.097

11.175

3.773

 

TOTAL

3189.067

2746.495

2592.069

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

2401.947

1938.934

2001.479

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(62.860)

91.054

(63.690)

 

Employee benefit expense

290.635

248.400

207.158

 

CSR expenditure

2.162

2.679

0.000

 

Other expenses

271.619

250.062

208.686

 

TOTAL

2903.503

2531.129

2353.633

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

285.564

215.366

238.436

 

 

 

 

 

Less

FINANCIAL EXPENSES

49.875

70.591

57.299

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

235.689

144.775

181.137

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

94.605

87.771

74.048

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

141.084

57.004

107.089

 

 

 

 

 

Less

TAX

49.418

11.524

51.275

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

91.666

45.480

55.814

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

 

 

 

-       Basic

16.40

8.70

11.16

 

-       Diluted

15.58

8.51

11.16

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

85.218

507.838

48.341

Net cash flows from (used in) operating activities

69.357

473.262

(25.249)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

70.08

73.68

95.70

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

5.21

4.95

3.81

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

116.51

143.08

97.72

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.72

0.79

0.74

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.40

0.33

0.43

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.50

0.50

0.68

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.34

0.31

1.12

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.90

0.85

1.84

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.48

0.46

0.86

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

5.73

3.05

4.16

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

PAT to Sales

((PAT / Sales) * 100)

%

2.90

1.66

2.16

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

3.02

1.62

2.79

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

6.12

3.23

8.72

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.00

1.21

0.95

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.71

0.98

0.67

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.49

0.50

0.32

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

6.03

5.15

14.30

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.00

1.21

0.95

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

50.000

85.294

85.294

Reserves & Surplus

590.251

1321.313

1412.979

Net worth

640.251

1406.607

1498.273

 

 

 

 

Long-term borrowings

174.913

200.325

181.879

Short term borrowings

539.877

239.268

332.242

Total borrowings

714.790

439.593

514.121

Debt/Equity ratio

1.116

0.313

0.343

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

2588.296

2735.320

3160.970

 

 

5.680

15.561

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

2588.296

2735.320

3160.970

Profit/ (Loss)

55.814

45.480

91.666

 

2.16 %

1.66 %

2.90 %

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

REVIEW OF BUSINESS OPERATIONS AND FUTURE PROSPECTS

 

The Company reported a marginal growth in revenue from operations of 16% over the previous year, at standalone level the gross revenue from operations for the financial year 2016-17 stood at INR 3160.970 Million compared with INR 2735.320 Million in the previous year. The Operating Profit before tax stood at INR 141.080 Million as against INR 57.000 Million in the previous years and the net profit for the year stood at INR 91.670 million against INR 45.480 Million reported in previous year, the Company has achieved a growth of approximately 100% in comparison to last year’s profit generation. This became possible by the effective management and control of the expenses of the Company with strict marketing strategy and effective workforce.

 

The company is continuously increasing its ability to consolidate its market in the export front. The Company is now receiving and executing orders from countries like Sri Lanka, Vietnam, Thailand, Fiji, Myanmar, Philippines etc. The efforts are on to expand and consolidate the exports.

 

 

INDEX OF CHARGES:

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G07648165

10608708

HDFC BANK LIMITED

09/10/2015

02/07/2016

-

167000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG, LOWER PAREL (WEST) MUMBAI MH400013IN

2

C48130926

10557714

SIDBI

26/03/2015

-

-

49500000.0

RAJPUR ROAD DEHRADUN UR248001IN

3

C68176247

10547318

INDUSIND BANK LIMITED

04/02/2015

14/10/2015

-

100000000.0

DR. GOPAL DAS BUILDING 28, BARAKHAMBA ROAD NEW DELHI DL110001IN

4

C01107804

10486705

HDFC BANK LIMITED

07/02/2014

-

-

65000000.0

HDFC BANK HOUSE SENAPATI BAPAT MARG LOWER PAREL W MUMBAI MH400013IN

5

C68198530

10313237

INDUSIND BANK LIMITED

29/09/2011

14/10/2015

-

158000000.0

DR. GOPAL DAS BUILDING28, BARAKHAMBA ROAD NEW DELHI DL110001IN

6

B17700865

10309166

HDFC BANK LIMITED

29/12/2010

-

-

50000000.0

HDFC BANK HOUSE SENAPATI BAPAT MARG LOWER PAREL W MUMBAI MH400013IN

7

G07114572

10223457

HDFC BANK LIMITED

28/04/2010

30/05/2016

-

233000000.0

HDFC BANK HOUSE, SENAPATI BAPAT MARG LOWER PAREL (W) MUMBAI MH400013IN

8

B97774152

90048511

STATE BANK OF INDIA

28/05/2001

15/02/2014

-

216600000.0

SME BRANCH69 RAJPUR ROAD, KRISHNA TOWER DEHRADUN UR248001IN

9

G06450498

10452654

THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED

09/10/2013

28/07/2014

27/05/2016

180000000.0

25, BARAKHAMA ROAD NEW DELHI DL110001IN

10

G06484703

10517922

THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED

08/05/2014

25/05/2015

27/05/2016

180000000.0

BIRLA TOWER25 BARAKHAMBA ROAD, NEW DELHI DL110001IN

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixture

·         Office Equipment

·         Computer

·         Vehicles

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 68.02

UK Pound

1

INR 91.25

Euro

1

INR 80.07

 

 

INFORMATION DETAILS

 

Information Gathered by :

SHK

 

 

Analysis Done by :

NIS

 

 

Report Prepared by :

NKT

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.